Your browser is no longer supported. Please, upgrade your browser.
TMO Thermo Fisher Scientific Inc. monthly Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E38.66 EPS (ttm)12.21 Insider Own0.10% Shs Outstand395.00M Perf Week-2.10%
Market Cap187.38B Forward P/E24.45 EPS next Y19.30 Insider Trans-47.19% Shs Float394.99M Perf Month6.88%
Income4.88B PEG2.49 EPS next Q5.73 Inst Own92.10% Short Float0.60% Perf Quarter13.99%
Sales28.50B P/S6.58 EPS this Y22.10% Inst Trans0.66% Short Ratio1.90 Perf Half Y43.08%
Book/sh75.63 P/B6.24 EPS next Y7.83% ROA6.20% Target Price462.16 Perf Year56.32%
Cash/sh- P/C- EPS next 5Y15.53% ROE12.50% 52W Range250.21 - 490.71 Perf YTD45.25%
Dividend0.88 P/FCF55.16 EPS past 5Y14.30% ROI8.50% 52W High-3.84% Beta1.01
Dividend %0.19% Quick Ratio2.00 Sales past 5Y8.60% Gross Margin47.80% 52W Low88.59% ATR10.38
Employees75000 Current Ratio2.60 Sales Q/Q9.50% Oper. Margin16.10% RSI (14)57.01 Volatility1.84% 2.10%
OptionableYes Debt/Eq0.71 EPS Q/Q4.60% Profit Margin12.90% Rel Volume1.06 Prev Close476.71
ShortableYes LT Debt/Eq0.69 EarningsOct 21 BMO Payout8.30% Avg Volume1.25M Price471.88
Recom1.70 SMA201.69% SMA506.96% SMA20028.51% Volume1,328,537 Change-1.01%
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
May-30-19Initiated Wolfe Research Outperform
May-23-19Reiterated Needham Strong Buy $313 → $315
Apr-22-19Reiterated Needham Strong Buy $271 → $312
Apr-16-19Reiterated BofA/Merrill Buy $285 → $300
Jan-03-19Initiated Needham Strong Buy $271
Oct-18-18Downgrade Cleveland Research Buy → Neutral
Oct-09-18Initiated UBS Buy
Oct-29-20 02:12PM  
11:20AM  
11:08AM  
10:21AM  
09:33AM  
09:08AM  
09:03AM  
08:00AM  
07:58AM  
07:56AM  
Oct-28-20 12:47PM  
12:06PM  
11:30AM  
11:25AM  
Oct-26-20 08:00AM  
Oct-23-20 08:39AM  
Oct-22-20 04:10PM  
Oct-21-20 04:17PM  
03:30PM  
10:21AM  
10:19AM  
10:08AM  
09:34AM  
09:18AM  
07:30AM  
07:12AM  
06:13AM  
06:00AM  
Oct-20-20 01:04PM  
10:18AM  
09:27AM  
08:15AM  
08:01AM  
07:40AM  
07:28AM  
Oct-19-20 09:49AM  
09:15AM  
08:58AM  
08:49AM  
08:00AM  
07:46AM  
Oct-17-20 04:53AM  
01:08AM  
Oct-14-20 12:34PM  
12:31PM  
10:01AM  
08:00AM  
06:15AM  
Oct-13-20 05:45PM  
09:45AM  
08:39AM  
08:37AM  
05:42AM  
Oct-12-20 11:30AM  
09:59AM  
09:45AM  
08:59AM  
08:00AM  
Oct-09-20 07:36AM  
Oct-08-20 11:30AM  
10:17AM  
08:44AM  
Oct-07-20 12:51PM  
12:11PM  
11:20AM  
08:22AM  
07:56AM  
Oct-06-20 05:45PM  
01:01PM  
11:33AM  
10:27AM  
10:18AM  
09:14AM  
09:12AM  
07:34AM  
Oct-05-20 08:00AM  
Oct-02-20 01:45PM  
12:10PM  
09:57AM  
06:28AM  
Oct-01-20 09:15AM  
Sep-30-20 11:06AM  
09:41AM  
09:35AM  
Sep-29-20 06:20AM  
Sep-28-20 05:45PM  
02:05PM  
10:25AM  
Sep-25-20 11:30AM  
08:00AM  
Sep-24-20 09:20AM  
Sep-23-20 11:18AM  
Sep-22-20 05:45PM  
Sep-21-20 01:42PM  
Sep-18-20 09:56AM  
08:00AM  
Sep-17-20 09:15AM  
Sep-16-20 05:45PM  
Sep-15-20 08:00PM  
03:30PM  
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrodinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; and an agreement with Daiichi Sankyo to co-develop a companion diagnostic. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOOct 27Sale487.8310,0004,878,287211,594Oct 28 05:18 PM
CASPER MARC NChairman & CEOOct 26Sale479.9410,0004,799,386221,594Oct 28 05:18 PM
Stevenson MarkExecutive Vice President & COOAug 25Option Exercise131.0722,0002,883,54056,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 25Sale420.1622,0009,243,52034,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 24Option Exercise131.0722,0002,883,54070,621Aug 25 04:04 PM
Stevenson MarkExecutive Vice President & COOAug 24Sale429.5522,0009,450,10048,621Aug 25 04:04 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Option Exercise136.503,337455,51219,862Aug 19 04:20 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Sale418.823,3371,397,61918,212Aug 19 04:20 PM
CASPER MARC NChairman & CEOJul 31Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 31Sale409.0220,0008,180,400240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Sale405.3120,0008,106,200240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 29Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
Williamson StephenSr. VP and CFOJul 29Option Exercise131.0719,8002,595,18657,789Jul 31 04:03 PM
Williamson StephenSr. VP and CFOJul 29Sale410.8319,8008,134,47137,989Jul 31 04:03 PM
CASPER MARC NChairman & CEOJul 29Sale411.0520,0008,221,015240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Sale411.6220,0008,232,400240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 27Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
Jafry Syed A.Sr. Vice PresidentJul 27Option Exercise181.0820,5133,714,47927,219Jul 29 04:09 PM
CASPER MARC NChairman & CEOJul 27Sale404.4020,0008,088,000240,446Jul 28 04:13 PM
Jafry Syed A.Sr. Vice PresidentJul 27Sale414.9420,5138,511,64621,019Jul 29 04:09 PM
Stevenson MarkExecutive Vice President & COOJul 24Option Exercise124.2825,0003,107,00073,621Jul 28 04:06 PM
CASPER MARC NChairman & CEOJul 24Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
CASPER MARC NChairman & CEOJul 24Sale403.3720,0008,067,400240,446Jul 28 04:13 PM
MANZI JIM PDirectorJul 24Sale402.383,2181,294,86518,986Jul 28 04:01 PM
Stevenson MarkExecutive Vice President & COOJul 24Sale404.5825,00010,114,46548,621Jul 28 04:06 PM
CASPER MARC NChairman & CEOJun 02Option Exercise124.2814,7951,838,723289,741Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 02Sale349.5514,7955,171,606274,946Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 01Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
Williamson StephenSr. VP and CFOJun 01Sale348.002,500870,00037,989Jun 02 04:21 PM
CASPER MARC NChairman & CEOJun 01Sale349.8920,0006,997,718274,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Sale349.2620,0006,985,200274,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 18Option Exercise124.2816,7052,076,097291,651May 20 05:07 PM
Stevenson MarkExecutive Vice President & COOMay 18Option Exercise124.2825,0003,107,00073,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Sale349.4416,7055,837,472274,946May 20 05:07 PM
Stevenson MarkExecutive Vice President & COOMay 18Sale348.7825,0008,719,57548,621May 20 04:47 PM
CASPER MARC NChairman & CEOApr 28Option Exercise124.2830,0003,728,400304,946Apr 29 04:22 PM
CASPER MARC NChairman & CEOApr 28Sale333.0230,0009,990,609274,946Apr 29 04:22 PM
Stevenson MarkExecutive Vice President & COOApr 24Option Exercise124.2825,0003,107,00073,538Apr 27 06:55 PM
Stevenson MarkExecutive Vice President & COOApr 24Sale328.0325,0008,200,65548,538Apr 27 06:55 PM
Williamson StephenSr. VP and CFOMar 04Option Exercise124.288,7001,081,23649,189Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Option Exercise124.2825,0003,107,00073,538Mar 05 04:59 PM
Williamson StephenSr. VP and CFOMar 04Sale318.548,7002,771,29840,489Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Sale324.2825,0008,107,00048,538Mar 05 04:59 PM
Lagarde MichelExecutive Vice PresidentMar 04Sale318.5412,0003,822,48026,385Mar 05 04:28 PM
Lagarde MichelExecutive Vice PresidentMar 03Sale319.8112,0003,837,72038,385Mar 05 04:28 PM
Williamson StephenSr. VP and CFOMar 02Sale291.032,500727,57540,489Mar 04 04:00 PM
CASPER MARC NChief Executive OfficerFeb 11Option Exercise124.2830,0003,728,400278,731Feb 13 04:07 PM
CASPER MARC NChief Executive OfficerFeb 11Sale337.1330,00010,114,048248,731Feb 13 04:07 PM
MANZI JIM PDirectorFeb 05Sale332.324,4101,465,53121,632Feb 06 04:32 PM
Williamson StephenSr. VP and CFOFeb 03Sale319.133,2681,042,91734,402Feb 05 05:59 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.